We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+5.26%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$224B
AUM Growth
+$21B
Cap. Flow
+$7.48B
Cap. Flow %
3.33%
Top 10 Hldgs %
24.57%
Holding
10,190
New
1,427
Increased
4,227
Reduced
3,278
Closed
1,044

Top Buys

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$798M
2
T icon
AT&T
T
+$527M
3
MCHP icon
Microchip Technology
MCHP
+$472M
4
NFLX icon
Netflix
NFLX
+$446M
5
PNC icon
PNC Financial Services
PNC
+$444M

Top Sells

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$694M
2
KEY icon
KeyCorp
KEY
+$401M
3
DE icon
Deere & Co
DE
+$322M
4
CSX icon
CSX Corp
CSX
+$318M
5
NXPI icon
NXP Semiconductors
NXPI
+$314M

Sector Composition

Rank Sector Weight
1 Financials 5.93%
2 Technology 4.66%
3 Healthcare 4.45%
4 Industrials 4.14%
5 Consumer Discretionary 3.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNNA
8051
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$200K ﹤0.01%
+13,467
New +$214K
ADTN icon
8052
CALL
Adtran
ADTN
$673M
$199K ﹤0.01%
+11,300
New +$189K
AGEN
8053
CALL
Agenus
AGEN
$327M
$199K ﹤0.01%
4,749
+3,042
+178% +$120K
ADAM
8054
PUT
Adamas Trust
ADAM
$903M
$199K ﹤0.01%
8,200
-8,075
-50% -$202K
RITM icon
8055
Rithm Capital
RITM
$5.8B
$199K ﹤0.01%
11,180
-632,608
-98% -$11.5M
SEM
8056
CALL
DELISTED
Select Medical
SEM
$199K ﹤0.01%
20,045
-8,723
-30% -$90.3K
FAX
8057
abrdn Asia-Pacific Income Fund
FAX
$597M
$198K ﹤0.01%
7,981
-1,010
-11% -$25.7K
NVAX icon
8058
CALL
Novavax
NVAX
$1.31B
$198K ﹤0.01%
5,265
+3,915
+290% +$110K
CASA
8059
DELISTED
Casa Systems, Inc. Common Stock
CASA
$198K ﹤0.01%
13,465
-433,986
-97% -$6.6M
ZYNE
8060
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$198K ﹤0.01%
+24,278
New +$186K
SNR
8061
CALL
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
$198K ﹤0.01%
33,500
+2,800
+9% +$18.5K
BATT icon
8062
Amplify Lithium & Battery Technology ETF
BATT
$124M
$196K ﹤0.01%
12,678
-13,573
-52% -$217K
GCAP
8063
DELISTED
Gain Capital Holdings, Inc.
GCAP
$196K ﹤0.01%
30,148
-87,566
-74% -$633K
ADAP
8064
CALL
DELISTED
Adaptimmune Therapeutics
ADAP
$195K ﹤0.01%
14,400
-600
-4% -$6.29K
RMTI icon
8065
Rockwell Medical
RMTI
$29.4M
$195K ﹤0.01%
419
-29
-6% -$14K
TPH
8066
DELISTED
Tri Pointe Homes
TPH
$195K ﹤0.01%
15,738
-1,012,050
-98% -$15M
VIAV icon
8067
PUT
Viavi Solutions
VIAV
$10.5B
$195K ﹤0.01%
+17,200
New +$186K
FPI
8068
CALL
Farmland Partners
FPI
$432M
$194K ﹤0.01%
28,900
+10,500
+57% +$72.1K
MRCC
8069
CALL
DELISTED
Monroe Capital Corp
MRCC
$194K ﹤0.01%
+14,300
New +$195K
GNE icon
8070
CALL
Genie Energy
GNE
$384M
$193K ﹤0.01%
+35,800
New +$199K
PXLW icon
8071
PUT
Pixelworks
PXLW
$44.5M
$193K ﹤0.01%
3,575
-1,508
-30% -$75.6K
SGC icon
8072
Superior Group of Companies
SGC
$208M
$193K ﹤0.01%
+10,155
New +$199K
APF
8073
DELISTED
Morgan Stanley Asia Pacific Fund
APF
$193K ﹤0.01%
+11,717
New +$197K
AKBA icon
8074
CALL
Akebia Therapeutics
AKBA
$242M
$192K ﹤0.01%
21,700
+7,500
+53% +$67.1K
CIA icon
8075
CALL
Citizens
CIA
$200M
$192K ﹤0.01%
22,800

Similar funds

Citadel Advisors's Q3 2018 Portfolio in Review

As of Q3 2018, Citadel Advisors held 10,190 positions worth $224B, up 10% from $203B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Citadel Advisors deployed $7.48B of net new capital in Q3 2018, opening 1,427 new positions and adding to 4,227 existing holdings. Its largest new stake was Alibaba: 1,030,311 shares worth $170M.

By sector, the portfolio is most concentrated in Financials at 5.9% of assets, down from 6.2% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Goldman Sachs, an estimated $694M trimmed.

  • Citadel Advisors's largest Q3 2018 buy was Alibaba: 1,030,311 shares worth $170M.
  • Citadel Advisors added most to Morgan Stanley in Q3 2018, an estimated $798M increase.
  • Citadel Advisors's biggest Q3 2018 reduction was Goldman Sachs, cutting an estimated $694M.
  • Citadel Advisors fully exited XL Group Ltd. in Q3 2018, selling an estimated $207M.
  • Citadel Advisors's ten largest holdings make up 25% of its $224B portfolio in Q3 2018.
  • Citadel Advisors opened 1,427 new positions and closed 1,044 in Q3 2018.
  • Citadel Advisors's portfolio value rose 10% quarter-over-quarter to $224B.

Based on Citadel Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.